Supporting Treatment Adherence Regimens in young children with epilepsy and their families: Trial design and baseline characteristics

This article describes the methodology, recruitment, design, and baseline participant characteristics of the Supporting Treatment Adherence Regimens (STAR) trial. STAR is a randomized controlled clinical trial of an education and problem-solving adherence intervention for young children (2 –12 years old) with newly diagnosed epilepsy and their families. Using an enrichment design, only participants who demonstrated non-adherence to antiseizure drugs within the baseline period were randomized to treatment or control arms.
Source: Contemporary Clinical Trials - Category: Radiology Authors: Source Type: research